盘点:眼科研究进展!

2017-12-18 cuiguizhong MedSci原创

  1. 眼科基础研究 J Glaucoma:开角型青光眼与脑卒中的关系:2010年至2012年韩国全国健康与营养调查! 首尔大学医学院眼科的Lee WJ近日在J Glaucoma杂志上发表了他们的一项工作,他们确定了韩国人群中开角型青光眼(OAG)与卒中之间的关系。 结果他们发现,中风患者OAG患病率(8.5%)显着高于非中风患者(3.8%; P <0.

 

1. 眼科基础研究

J Glaucoma:开角型青光眼与脑卒中的关系:2010年至2012年韩国全国健康与营养调查!

首尔大学医学院眼科的Lee WJ近日在J Glaucoma杂志上发表了他们的一项工作,他们确定了韩国人群中开角型青光眼(OAG)与卒中之间的关系。

结果他们发现,中风患者OAG患病率(8.5%)显着高于非中风患者(3.8%; P <0.001)。在筛选危险因素后,出现OAG更倾向于与患有卒中相关(校正OR = 1.629),但是这个结果没有统计学意义(P = 0.053)。在高血压(OR = 2.059; P = 0.010)和糖尿病(OR = 2.649; P = 0.040)患者中,卒中和OAG存在显着的相关性。另外,当出现OAG时患有其他疾病,中风和其他全身性疾病的关联性更强。因此,他们认为,尽管没有统计学意义,但OAG患者中有高血压糖尿病等全身性并发症的风险增加。他们的研究结果提供了一个很好的视角,来了解OAG发生机制及其与中风发展的关系。

J Physiol:多种抑制性和兴奋性机制在兔视网膜中的瞬时关闭α神经节细胞中形成时间调谐!

美国俄勒冈州健康科学大学凯西眼科研究所的Murphy-Baum BL近日在J Physiol杂志上发表了他们的一项工作,他们在兔子的视网膜中发现,多种抑制性和兴奋性机制在瞬时关闭α神经节细胞中形成时间调谐。

在发表的文章中,他们发现,在兔子视网膜中兴奋性突触输入信号传递到瞬态关闭的α神经节细胞(t-OFFαGCs)。他们的研究表明,兴奋性和抑制性突触输入信号都传递到突触前的双极细胞末端,t-OFFαGC细胞将时间调谐转移到更高的时间频率。 GABA能抑制性神经细胞可以抑制低频的兴奋性输入信号,但在高频时会有增强作用。突触前双极细胞中的TTX敏感通道也有助于提高对高频信号的响应。在突触前双极细胞中存在甘氨酸能抑制性和钠通道激活性的交叉信号传递也加强了对高频兴奋性输入信号的处理能力。

他们的这项发现具有重要意义,这些机制的空间和时间属性和对敏感度的差异是目前了解较少的方面。在不同的视觉条件下,t-OFFαGC对刺激信号的选择性差异,导致在这些机制的作用下具有不同频率的调节功能。

Invest Ophthalmol Vis Sci:在实验性大鼠青光眼模型中发现Ghrelin抑制视网膜神经细胞自噬和凋亡!

复旦大学上海眼耳鼻喉科医院眼科和上海市视觉障碍与修复重点实验室的Zhu K近日发表了他们实验室的一项重要工作,在慢性眼内高压(COH)大鼠模型中,发现生长素释放激素可能通过激活ghrelin / GHSR-1a系统,从而抑制视网膜自噬、神经节细胞凋亡和Müller细胞胶质的细胞增生,进而在视网膜中发挥神经保护的作用。

经过研究发现,眼压升高引起视网膜细胞(包括RGC和Müller细胞)中ghrelin和GHSR-1a表达的显着增加。 Western blot证实,手术后第2周(G2w)Ghrelin蛋白水平呈现瞬时性上调,在手术后第二周(G2w)到第四周(G4w),GHSR-1a蛋白水平维持在较高的水平。在COH视网膜中,两种自噬相关的蛋白LC3-II / LC-I和beclin1的比例从G1w增加至G4w,并且从G2w至G4w检测到凋亡执行蛋白caspase3的切割产物。经腹膜内注射ghrelin,发现存活的RGC的数量显着增加,LC3-II / LC-I、beclin1和caspase3裂解产物等得到抑制,并且COH视网膜中TUNEL阳性细胞的数量减少。Ghrelin处理也使得p-Akt和p-mTOR下降趋势得到逆转,上调GHSR-1a蛋白质水平,并减弱了COH视网膜中的胶质纤维酸性蛋白质水平。

这些结果表明,生长素释放激素可能通过激活ghrelin / GHSR-1a系统,从而抑制视网膜自噬、神经节细胞凋亡和Müller细胞胶质的细胞增生,从而在COH视网膜中发挥神经保护的作用。

Eur Rev Med Pharmacol Sci:缺氧刺激通过上调HIF-1α/ MMP9信号通路促进视网膜母细胞瘤细胞体外侵袭!

成都中医药大学眼科学院的Li YY近日在Eur Rev Med Pharmacol Sci发表了他们的一项新的工作,他们探讨了在视网膜母细胞瘤细胞株HXO-RB44中,缺氧对低氧诱导转录因子-1α(HIF-1α)/基质金属蛋白酶9(MMP9)信号通路的影响。

结果他们发现,缺氧可促进HXO-RB44细胞的侵袭。同时,在缺氧处理后,HIF-1α和MMP9的mRNA和蛋白水平均呈现上调,而HIF-1α和MMP9 siRNA实验可以反向验证。因此,他们认为,缺氧刺激通过激活HIF-1α/ MMP9信号通路,促进视网膜母细胞瘤HXO-RB44细胞的侵袭过程。

2. 眼科病例报告

Eur J Ophthalmol:双侧色素黄斑病和前段发育不良的罕见病例!

英国伦敦国王学院医院和NHS基金会玛丽皇后医院眼科的Bloch E近日在Eur J Ophthalmol发表了他们的一项工作,首次报道了一例双侧色素性黄斑病和前段发育不良的独特病例。

他们报道了一例案例,一名49岁女性患者双眼的视力长期下降,前段发育不全,出现多发性色素沉着病变。视网膜电图检查结果证实是严重的黄斑功能障碍。基因阵列分析没有发现任何染色体形态不正常或其他特异性的异常。因此,他们认为,这个病例是双侧色素性黄斑病和前段发育不全的独特病例,临床发现不属于先前报道的疾病的特征。

Cornea环孢素治疗结膜良性活动性淋巴结增生症。

美国宾夕法尼亚大学谢赫眼科研究所眼科的Parikh RN 近日在Cornea发表了他们的一项工作,他们报告了在应激性淋巴样增生(RLH)的病例中,结膜对环孢霉素免疫抑制剂单药治疗的响应情况。

一名66岁的男性患者,经过活检证实,有2年的双侧应激性淋巴样增生的病史。因病人反应有双眼烧灼、刺痛的感觉,其主要的并发症为干眼症。经裂隙灯检查,患者泪膜中基质金属蛋白酶9为阳性,诊断为睑板腺功能不全和泪液功能不全的干眼症。随后在患者双眼中,局部使用环孢霉素(眼用乳剂0.5mg / mL,每天2次)进行治疗。结果发现,在3个月的随访中,发现双侧应激性淋巴样增生病变显着减少。

这个报告是第一例良性眼部应激性淋巴样增生响应局部环孢霉素治疗的病例。作者认为,环孢霉素可能在治疗良性眼部应激性淋巴样增生患者方面具有重要作用,需要进一步的研究来评估其疗效。

3. 眼科临床治疗进展

Eye (Lond):Vogt-Koyanagi-Harada病患者不同部位之间光感受器恢复的差异!

上海复旦大学上海医学院眼科和耳鼻喉科医院眼科的Zhou M近日在Eye (Lond)发表了他们的一项工作,探讨了Vogt-Koyanagi-Harada(VKH)疾病治疗后光感受器的恢复情况。

结果他们发现,患者眼底不同部位的光感受器恢复情况不同。 F组56眼中,10只眼的椭圆形区(EZ)得到恢复,17只眼的交错区(IZ)得到恢复。在大多数眼睛中(其中EZ 有46例眼,IZ有 26例眼),这些结构的恢复类型是S型。仅在10只眼中,IZ的恢复是E型。通过比较治疗后12个月的解剖和视力结果发现,不同的恢复模式与患者的不同的恢复治疗方式有关。与对照组相比,F组患者延迟治疗,EZ或IZ恢复延迟,12个月时预后较差,而E组患者治疗和恢复最为迅速,且更为有利。因此,他们认为,在延迟治疗的VKH患者中,中央凹感光器的恢复速度比其他区域的感光器更快。

Clin Exp Rheumatol:通过检测抗阿达木单抗抗体水平可以更好的治疗青少年特发性关节炎相关葡萄膜炎!

芬兰赫尔辛基大学医院赫尔辛基大学眼科的Leinonen ST 近日在Clin Exp Rheumatol发表了他们近期的一项工作,他们对阿达木单抗和抗阿达木单抗抗体与青少年特发性关节炎相关葡萄膜炎活性之间的关系进行了研究,他们发现通过检测抗阿达木单抗抗体水平可以更好的治疗青少年特发性关节炎相关葡萄膜炎!

他们发现,在9名患者(29%)中检测到抗阿达木单抗抗体的水平超过12AU/ ml。这一水平的抗阿达木单抗抗体与葡萄膜炎的发生存在显着的相关性(p <0.001),也与葡萄膜炎持续发展(p = 0.001)和甲氨蝶呤治疗缺乏存在显着的相关性(p = 0.043)。在抗阿达木单抗抗体水平低于12 AU / ml的患者中,较高的血清峰值水平与更好地控制葡萄膜炎的发展没有显着的相关性(p = 0.86)。因此,他们认为,在治疗青少年特发性关节炎相关葡萄膜炎的过程中,通过监测抗阿达木单抗抗体的形式更好地指导阿达木单抗治疗方案的实施。

Med Sci Monit:诊断眼部真菌病的临床评分系统!

土耳其布尔萨Uludag大学医学院眼科的OzmenAT2近日在Med Sci Monit杂志上发表了他们的一项新的工作,他们开发了一个系统的评分系统,使之可以在没有先进设施的情况下,对由蠕形螨引起的慢性睑缘炎进行非常准确的诊断,并发现茶树油治疗慢性睑缘炎具有很好的效果。

经过分析,患者的平均年龄为54.1±15.4岁。男性有17例,占群体的43.5%,女性患者有22例,占56.5%。在39名患者中有30名(76.9%)检测到D.fullliculorum。 25例患者症状消失。 Demodex阴性患者平均得分为2.7±1.0,Demodex阳性患者平均得分为3.8±1.6(p = 0.047)。发现4分和4分以上的患者中有94%是蠕形螨阳性(p = 0.025)。

因此,他们认为,用茶树油治疗蠕形螨引起的慢性睑缘炎具有很好的效果。如果在光学显微镜下无法确定是否存在蠕形螨,他们建议可以使用本研究中开发的评分表进行诊断,对4分以上的患者进行治疗。

J AAPOS:贝伐单抗与激光治疗对早产儿视网膜病变的疗效和发育影响!

德克萨斯州大学休斯顿健康科学中心麦戈文医学院儿科的Kennedy KA近日在J AAPOS发表了一篇新的文章,他们比较了对早产儿视网膜病变治疗过程中,贝伐单抗治疗与激光治疗对发育是否有不良影响。

在他们现场招募的18名婴儿中,有16名(7名贝伐珠单抗治疗和9名激光治疗)在18-28个月时进行医疗和神经发育等分析。与正常婴儿的标准相比,每个组的中位数和生长百分位数范围较低。 Bayley III发育得分的范围也低于健康婴儿的预期标准。贝伐单抗组与激光治疗组在体重(中位百分数:贝伐单抗,18;激光,7)、长度、头围,脑瘫或Bayley评分(中位认知综合评分:贝伐珠单抗,85;激光, 65)等方面没有显着的差异。在住院时间长短方面有显着的差异,贝伐单抗治疗组中位数为98天。因此,他们认为,在这项患者队列的研究中,通过2年的随访发现,贝伐单抗治疗的婴儿与激光治疗的早产儿视网膜病变对医疗或神经发育等情况没有不良影响。

4. 眼科手术新进展

Ophthal Plast Reconstr Surg:利用内窥镜进行角膜神经重建--技术和初步经验

美国北卡罗来纳州杜克大学医院眼科学部眼科整形与整形外科的Leyngold 及其同事近日发表了一项新的工作,作者描述了一种微创手术技术,用于在神经营养性角膜病患者的眼内,通过内窥镜的方式收集眼眶上神经,进而重建角膜感觉。

具体的手术方法是,在小眼睑皱褶和头皮切口,利用内窥镜观察,收集对侧眼眶上的神经,转移至受影响的眼睛。手术结果表明,角膜神经重建成功,恢复了角膜的敏感性和角膜上皮的完整性。因此,他们认为,使用内窥镜可以允许通过微创的方法,利用眼眶上的神经成功地进行角膜神经重建。

Eur J Ophthalmol:老花眼矫正手术中小切口微透镜提取(SMILE)单眼视力检查!

德国慕尼黑路德维希 - 马克西米利安大学眼科医院的Luft N近日在Eur J Ophthalmol发表了他们的一项工作,他们在老花眼人群中研究了近视小切口微透镜提取(SMILE)单眼视力的结果。

研究群体的平均年龄为49±3岁,女性与男性的比例为30:19。在80%的患者中,距离眼睛获得了与目标屈光度±0.50D的等效球镜矫正,96%在±1.0D之内。达到20/20或更高的双眼UDVA达到90%,所有患者达到20/25或更好。双眼UDVA为20/20或更高的患者阅读J2或更好的比例达84%。 84%的患者获得了独立的眼镜独立性,92%的患者获得独立眼镜的独立性。没有病人要求进行屈光增强。因此,他们认为,这是首次报道的SMILE 单眼视力评估研究。对于寻找屈光手术的近视患者,这种方法是矫正老花眼的安全有效的方法。

Adv Ther:白内障超声乳化术对小梁切除术后高眼压患者眼压的影响!

意大利布雷西亚布雷西亚大学医学和外科专业的Quaranta L近日在Adv Ther杂志上发表了他们的一项新的工作,他们在低眼压黄斑病变患者中,经过白内障摘除手术和小梁切除术后,评估这些患者的视力变化。

从2010年1月至2014年9月,连续20名成年患者符合纳入标准。超声乳化前,平均眼压为3.1±1.6 mmHg。白内障超声乳化术后1个月时,平均眼压升至8.6±4.1 mmHg(p <0.01),3个月时平均眼压升至9.1±4.3 mmHg(p <0.01)。在20只眼中有16只(80%)眼观察到超声乳化术后IOP升高。平均视力在晶状体乳化术后3个月时从Snellen 0.5±0.1提高到0.6±0.1(p <0.01)至0.7±0.2(p <0.01)。其中在4只眼的眼压不升高的情况下,进行了一次小梁切除术的手术修复。在超声乳化术3个月后研究发现,视力和IOP变化之间没有显着的相关性。

因此,他们认为,在视觉上影响不大的白内障患者中进行白内障超声乳化手术是一种安全有效的方法,用于治疗由于过度滤过引起的深层前房的慢性眼压降低的症状。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-20 半夏微凉

    学习了谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-20 1e17414fm02(暂无匿称)

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 太上老君1968

    henhao

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 神功盖世

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 yifandudu

    感谢!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 明月清辉

    谢谢分享.学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 刘煜

    谢谢分享.阅读

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1380926, encodeId=460b138092641, content=<a href='/topic/show?id=9281e34519b' target=_blank style='color:#2F92EE;'>#研究进展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73451, encryptionId=9281e34519b, topicName=研究进展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Wed Dec 20 14:42:00 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270926, encodeId=e0802e0926f6, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo5nmIH5IQqCKjJgSCuicPWUWOUcdqt1ROPnEiaOYN4pSHibDv8la3OxNLalvuvUXn8clpJlrpuyTpckgt9OPkeSSdT/0, createdBy=8fd71930726, createdName=半夏微凉, createdTime=Wed Dec 20 13:35:01 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270760, encodeId=5a192e076013, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfDEeydJz0GlP8O0ngrUX6AYCXFic0XDOOAyeQicIqnOd4TrWSwiagJrsFNYuWC1Uc6iavbS1hWt9xtZAhAqLGHqZyl/0, createdBy=42891977006, createdName=1e17414fm02(暂无匿称), createdTime=Wed Dec 20 05:14:05 CST 2017, time=2017-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270613, encodeId=bdab2e061356, content=学习了新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Dec 19 10:36:43 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270574, encodeId=69632e0574e3, content=henhao, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/0, createdBy=508e2136543, createdName=太上老君1968, createdTime=Tue Dec 19 09:55:23 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270559, encodeId=69bf2e055936, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Tue Dec 19 09:46:06 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270522, encodeId=9daf2e052294, content=感谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cc549454, createdName=yifandudu, createdTime=Tue Dec 19 07:46:28 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270511, encodeId=e5dd2e051164, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Dec 19 07:35:32 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270509, encodeId=fc002e0509e5, content=谢谢分享.阅读, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Tue Dec 19 07:35:13 CST 2017, time=2017-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=270506, encodeId=8ee12e050602, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/01/edc79b79a01c9a0c347eaff72537896a.jpg, createdBy=0b5c2207520, createdName=lixiangchun81_81153335, createdTime=Tue Dec 19 07:31:26 CST 2017, time=2017-12-19, status=1, ipAttribution=)]
    2017-12-19 lixiangchun81_81153335

    学习了

    0

相关资讯

Eur J Ophthalmol:歌剧中的盲人和视力障碍

土耳其安卡拉眼科和眼科门诊的Aydin P近日在Eur J Ophthalmol发表了他们近期一项有趣的工作。表演艺术可以反映人类的代表性情况。这项研究试图分析在歌剧中的视觉障碍人物失明或近盲的原因,以及失明的故事情节的戏剧性目的。

盘点:眼科疾病及治疗亮点文章11月上

1. 视网膜疾病及治疗J AAPOS:单侧贝伐珠单抗治疗对于早产儿视网膜病变的黄斑形态影响!西澳大利亚西兰大学眼科研究所眼科和视觉科学中心的Clark A近日在J AAPOS杂志上发表了他们近期的一项工作,他们进行了回顾性病例研究,评估了单侧玻璃体内贝伐珠单抗(IVB)治疗在单侧1型早产儿视网膜病变(ROP)中对黄斑厚度和中央凹发育的影响。单侧1型早产儿视网膜病变(ROP)的7名婴儿在一只眼睛

Eur J Ophthalmol:双侧色素黄斑病和前段发育不良的罕见病例!

英国伦敦国王学院医院和NHS基金会玛丽皇后医院眼科的Bloch E近日在Eur J Ophthalmol发表了他们的一项工作,首次报道了一例双侧色素性黄斑病和前段发育不良的独特病例。

Retin Cases Brief Rep:黄斑病-长期随访和病例研究!

澳大利亚新南威尔士州Wagga Wagga农村转诊医院的Hui M近日在Retin Cases Brief Rep发表了他们的一项工作,他们报告了一系列的黄斑病。

J AAPOS:脑白质性黄瘤病-基于青少年白内障的早期诊断!

美国俄勒冈州健康科学大学凯西眼科研究所眼科系的Tibbral S近日在J AAPOS杂志上发表了他们近期的一项工作,他们在文章中报告了一名儿童具有青少年双侧白内障的特征,并进行脑白质黄瘤病的诊断的病例。

Retin Cases Brief Rep:周围性色素上皮细胞的视网膜色素上皮剥离!

加利福尼亚大学旧金山分校眼科的Zhang F近日在Retin Cases Brief Rep发表了他们的一项工作,报告一名患有视网膜色素上皮脱离(PED)患者的病例,这些患者偶然会出现视网膜色素上皮脱离(PED)的现象。